Product
MBX 2109
2 clinical trials
2 indications
Indication
HealthyIndication
HypoparathyroidismClinical trial
A Phase 1, Randomized, Double Blind, Placebo Controlled, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Single and Multiple Ascending Doses of MBX 2109 in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-06-20
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of MBX 2109 in Patients With Hypoparathyroidism (AVAIL Study)Status: Recruiting, Estimated PCD: 2025-03-01